Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy

Gao Y, Li L, Zhao F, Cheng Y, Jin M, Xue FS

Drug Design, Development and Therapy 2025, 19:369-387

Published Date: 20 January 2025